Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Chemed Inc (CHE)

Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,824,044
  • Shares Outstanding, K 15,050
  • Annual Sales, $ 2,264 M
  • Annual Income, $ 272,510 K
  • EBIT $ 427 M
  • EBITDA $ 488 M
  • 60-Month Beta 0.46
  • Price/Sales 3.44
  • Price/Cash Flow 21.07
  • Price/Book 6.30

Options Overview Details

View History
  • Implied Volatility 22.67% ( -1.34%)
  • Historical Volatility 15.97%
  • IV Percentile 88%
  • IV Rank 71.04%
  • IV High 27.10% on 12/18/24
  • IV Low 11.83% on 08/21/24
  • Put/Call Vol Ratio 3.33
  • Today's Volume 13
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 344
  • Open Int (30-Day) 330

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 6.34
  • Number of Estimates 2
  • High Estimate 6.39
  • Low Estimate 6.29
  • Prior Year 6.60
  • Growth Rate Est. (year over year) -3.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
512.12 +1.44%
on 12/23/24
578.72 -10.23%
on 11/29/24
-53.94 (-9.41%)
since 11/26/24
3-Month
512.12 +1.44%
on 12/23/24
615.65 -15.62%
on 10/18/24
-80.55 (-13.42%)
since 09/26/24
52-Week
512.12 +1.44%
on 12/23/24
654.62 -20.64%
on 03/15/24
-72.61 (-12.26%)
since 12/26/23

Most Recent Stories

More News
Insider Sale: executive vice president of $CHE (CHE) Sells 732 Shares

SPENCER S LEE, the executive vice president of $CHE ($CHE), sold 732 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.8% of...

CHE : 519.51 (-0.07%)
Insider Sale: president and CEO of $CHE (CHE) Sells 2,000 Shares

KEVIN J MCNAMARA, the president and CEO of $CHE ($CHE), sold 2,000 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.9% of...

CHE : 519.51 (-0.07%)
Insider Sale: executive vice president of $CHE (CHE) Sells 1,000 Shares

SPENCER S LEE, the executive vice president of $CHE ($CHE), sold 1,000 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.0%...

CHE : 519.51 (-0.07%)
Chemed: Q3 Earnings Snapshot

Chemed: Q3 Earnings Snapshot

CHE : 519.51 (-0.07%)
Reasons to Retain Chemed Stock in Your Portfolio Now

Chemed Corporation CHE is expected to grow in the upcoming quarters, backed by the prospects of the VITAS business. Strength within the company’s Roto-rooter brand looks impressive. Meanwhile, Chemed’s...

AXGN : 17.00 (+4.55%)
CHE : 519.51 (-0.07%)
PAHC : 21.64 (unch)
TMDX : 63.60 (-0.47%)
Chemed: Q2 Earnings Snapshot

Chemed: Q2 Earnings Snapshot

CHE : 519.51 (-0.07%)
Chemed: Q1 Earnings Snapshot

Chemed: Q1 Earnings Snapshot

CHE : 519.51 (-0.07%)
Chemed: Q4 Earnings Snapshot

Chemed: Q4 Earnings Snapshot

CHE : 519.51 (-0.07%)
Chemed: Q3 Earnings Snapshot

Chemed: Q3 Earnings Snapshot

CHE : 519.51 (-0.07%)
Chemed: Q2 Earnings Snapshot

Chemed: Q2 Earnings Snapshot

CHE : 519.51 (-0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides...

See More

Key Turning Points

3rd Resistance Point 530.69
2nd Resistance Point 525.86
1st Resistance Point 522.86
Last Price 519.51
1st Support Level 515.03
2nd Support Level 510.20
3rd Support Level 507.20

See More

52-Week High 654.62
Fibonacci 61.8% 600.19
Fibonacci 50% 583.37
Fibonacci 38.2% 566.56
Last Price 519.51
52-Week Low 512.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar